Self-reported quality of life in users and nonusers of dietary supplements in cancer.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 16059680)

Published in Support Care Cancer on July 30, 2005

Authors

Christopher G Lis1, Jerrilyn A Cambron, James F Grutsch, Joel Granick, Digant Gupta

Author Affiliations

1: Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center, Zion, IL, USA. digant.gupta@ctca-hope.com

Articles cited by this

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA (1998) 35.46

Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med (1993) 28.86

Use of alternative medicine by women with early-stage breast cancer. N Engl J Med (1999) 7.37

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol (2000) 5.48

The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer (1998) 4.95

Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med (2001) 4.37

Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ (1994) 3.52

Varieties of healing. 2: a taxonomy of unconventional healing practices. Ann Intern Med (2001) 3.42

Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol (2000) 3.10

Quality of life index: development and psychometric properties. ANS Adv Nurs Sci (1985) 2.49

Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol (1995) 2.08

Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med (1991) 1.95

Psychometric assessment of the Quality of Life Index. Res Nurs Health (1992) 1.91

Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med (2002) 1.85

Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol (1997) 1.72

Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol (2001) 1.69

Defining and describing complementary and alternative medicine. Panel on Definition and Description, CAM Research Methodology Conference, April 1995. Altern Ther Health Med (1997) 1.39

Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer (2004) 1.31

Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med (2004) 1.29

Development of a quality of life index for patients with cancer. Oncol Nurs Forum (1990) 1.24

ABC of complementary medicine. Complementary medicine in conventional practice. BMJ (1999) 1.16

Development of a conceptual model of quality of life. Sch Inq Nurs Pract (1996) 1.14

The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer (2005) 0.96

Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Sch (1998) 0.91

Measuring quality of life in culturally diverse populations. J Natl Cancer Inst Monogr (1996) 0.85

Quality of life after coronary angioplasty. Heart Lung (1993) 0.85

Use of complementary and alternative medicine and quality of life: changes at the end of life. Palliat Med (2003) 0.79

Complementary and alternative medicine (CAM), cancer and group-based action: a critical review of the literature. Eur J Cancer Care (Engl) (2004) 0.79

Articles by these authors

Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies. Oncologist (2012) 1.70

The prognostic role of quality of life assessment in breast cancer. Breast J (2011) 1.64

Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther (2003) 1.64

The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer (2006) 1.63

Can patient satisfaction with quality of life predict survival in advanced colorectal cancer? Support Care Cancer (2006) 1.55

Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr (2004) 1.50

A randomized clinical trial and subgroup analysis to compare flexion-distraction with active exercise for chronic low back pain. Eur Spine J (2005) 1.33

Renal cell carcinoma with unusual metastasis to the small intestine manifesting as extensive polyposis: successful management with intraoperative therapeutic endoscopy. Case Rep Gastroenterol (2011) 1.32

Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol (2006) 1.28

Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr (2004) 1.27

Issues in planning a placebo-controlled trial of manual methods: results of a pilot study. J Altern Complement Med (2002) 1.22

The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage (2007) 1.16

Distribution and determinants of patient satisfaction in oncology: A review of the literature. Patient Prefer Adherence (2009) 1.13

Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer (2008) 1.12

Is serum albumin an independent predictor of survival in patients with breast cancer? JPEN J Parenter Enteral Nutr (2003) 1.09

Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer (2011) 1.08

Clinical utilization and cost outcomes from an integrative medicine independent physician association: an additional 3-year update. J Manipulative Physiol Ther (2007) 1.08

Role of nutritional status in predicting quality of life outcomes in cancer--a systematic review of the epidemiological literature. Nutr J (2012) 1.07

Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J (2011) 1.01

Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer (2009) 1.00

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health Qual Life Outcomes (2011) 0.99

The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer. Nutr J (2008) 0.99

The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer (2005) 0.96

Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J Circadian Rhythms (2011) 0.96

Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life. BMC Health Serv Res (2009) 0.95

Can patient experience with service quality predict survival in colorectal cancer? J Healthc Qual (2012) 0.94

A unique case of a nonfunctional metastatic pancreatic neuroendocrine tumor transforming into an insulin-secreting tumor with an unusual clinical course. Pancreas (2011) 0.94

The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer (2007) 0.93

Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer (2007) 0.91

Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology (2010) 0.91

Reliability of zygapophysial joint space measurements made from magnetic resonance imaging scans of acute low back pain subjects: comparison of 2 statistical methods. J Manipulative Physiol Ther (2010) 0.90

Cox decompression chiropractic manipulation of a patient with postsurgical lumbar fusion: a case report. J Chiropr Med (2011) 0.90

The relationship between perceived service quality and patient willingness to recommend at a national oncology hospital network. BMC Health Serv Res (2011) 0.89

Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J (2010) 0.89

Pilot study of the effect of a limited and extended course of chiropractic care on balance, chronic pain, and dizziness in older adults. J Manipulative Physiol Ther (2009) 0.89

The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer (2011) 0.88

Patient satisfaction with quality of life as a predictor of survival in pancreatic cancer. Int J Gastrointest Cancer (2006) 0.87

Distribution of cavitations as identified with accelerometry during lumbar spinal manipulation. J Manipulative Physiol Ther (2011) 0.87

The European organization for research and treatment of cancer quality of life questionnaire: implications for prognosis in pancreatic cancer. Int J Gastrointest Cancer (2006) 0.86

Dual chemotaxis signalling regulates Dictyostelium development: intercellular cyclic AMP pulses and intracellular F-actin disassembly waves induce each other. Eur J Cell Biol (2008) 0.85

Prevalence of nonmusculoskeletal versus musculoskeletal cases in a chiropractic student clinic. J Chiropr Educ (2013) 0.85

Percutaneous endoscopic gastrostomy tube occlusion in malignant peritoneal carcinomatosis-induced bowel obstruction. Eur J Gastroenterol Hepatol (2011) 0.84

Large C4/5 spondylotic disc bulge resulting in spinal stenosis and myelomalacia in a Klippel-Feil patient. J Altern Complement Med (2012) 0.83

Predicting survival in prostate cancer: the role of quality of life assessment. Support Care Cancer (2011) 0.83

The relationship between dyspnea and patient satisfaction with quality of life in advanced cancer. Support Care Cancer (2006) 0.82

Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer. Pancreas (2013) 0.81

Can anorexia predict patient satisfaction with quality of life in advanced cancer? Support Care Cancer (2008) 0.81

The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy. Nutr J (2013) 0.81

Patient satisfaction with health-related quality of life: implications for prognosis in prostate cancer. Clin Genitourin Cancer (2008) 0.81

Comparison of two quality of life instruments for cancer patients: the Ferrans and Powers Quality of Life Index and the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire C30. J Soc Integr Oncol (2008) 0.81

Outcomes of systematic nutritional assessment and medical nutrition therapy in pancreatic cancer. Pancreas (2015) 0.81

Prognostic value of changes in quality of life scores in prostate cancer. BMC Urol (2013) 0.80

Initial experience with genomic profiling of heavily pretreated breast cancers. Ann Surg Oncol (2014) 0.80

Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. J Soc Integr Oncol (2008) 0.79

The use of failure mode and effect analysis in a radiation oncology setting: the Cancer Treatment Centers of America experience. J Healthc Qual (2012) 0.79

Prevalence, sources, and predictors of soy consumption in breast cancer. Nutr J (2009) 0.78

Effect of naturopathic and nutritional supplement treatment on tumor response, control, and recurrence in patients with prostate cancer treated with radiation therapy. J Altern Complement Med (2012) 0.76

Colon carcinoma with unusual metastasis to the esophagus manifesting as multiple nodules and Dysphagia: management with systemic chemotherapy. Case Rep Gastroenterol (2012) 0.75

Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. BMC Cancer (2010) 0.75

A possible correlation between vitamin D deficiency and loss of smell: 2 case reports. J Chiropr Med (2011) 0.75

Community triage of otology patients using a store-and-forward telemedicine device: A feasibility study. Ear Nose Throat J (2017) 0.75

Clinical trial variability: quality control in a randomized clinical trial. Contemp Clin Trials (2008) 0.75